肝细胞癌 (HCC) 转移和侵袭中的信号通路:分子机制和治疗影响
Jayanta Das1, Bhupen Barman2, Phulen Sarma3
1Department of Biochemistry, All India Institute of Medical Sciences, Guwahati, 781101, India.
Biochemistry and biophysics reports
|January 1, 2026
概括
本综述详细介绍了驱动肝癌 (HCC) 转移和侵袭的信号通路. 它强调了分子机制,治疗点和治疗这种致命恶性瘤的挑战.
科学领域:
- 肝细胞癌 (HCC) 研究研究
- 癌症转移和入侵机制
- 分子瘤学和治疗学
背景情况:
- 肝细胞癌 (HCC) 由于其高死亡率和不良预后,对全球健康构成重大挑战.
- 转移和侵袭是决定HCC进展和患者结果的关键过程.
- 了解HCC攻击性的分子基础对于开发有效治疗方法至关重要.
研究的目的:
- 审查涉及HCC转移和侵袭的关键信号通路.
- 阐明这些途径的分子机制,交叉通话和治疗潜力.
- 解决HCC治疗的挑战,包括瘤异质性和治疗耐药性.
主要方法:
- 对HCC转移中信号通路的综合文献综述.
- 分子机制的分析,包括Wnt/β-catenin,TGF-β,PI3K/AKT/mTOR,MAPK/ERK,HGF/c-MET,Notch和Hippo-YAP/TAZ. 这三种分子机制的分析.
- 检查瘤微环境, stromal 相互作用, ECM 重塑,缺氧和血管生成.
主要成果:
- 确定了多种信号通路 (Wnt/β-catenin,TGF-β,PI3K/AKT/mTOR,MAPK/ERK,HGF/c-MET,Notch,Hippo-YAP/TAZ) 促进了攻击性的HCC行为.
- 突出了瘤微环境和相关因素在HCC进展中的作用.
- 讨论了当前的治疗策略 (氨酸激酶抑制剂,单克隆抗体) 和未来的研究方向.
结论:
- 针对特定的信号通路和瘤微环境,为HCC提供了有前途的治疗途径.
- 解决瘤变异和治疗耐药性对于改善HCC的临床结果至关重要.
- 需要进一步研究新的治疗点,以推进HCC治疗策略.
更多相关视频
08:40A Biomimetic Model for Liver Cancer to Study Tumor-Stroma Interactions in a 3D Environment with Tunable Bio-Physical Properties
Published on: August 7, 2020
6.7K
06:38An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
9.4K
相关概念视频
Interactions Between Signaling Pathways
7.1K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.1K
Non-Canonical Wnt Signaling Pathways
8.2K
Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
8.2K
Canonical Wnt Signaling Pathway
10.3K
The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
10.3K
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
Metastasis
6.3K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.3K
MAPK Signaling Cascades
7.8K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
7.8K
